Topas Therapeutics' Series A Round

Topas Therapeutics raised a round of funding on March 22, 2016.

Topas Therapeutics has developed a unique technology for the induction of antigen-specific immune tolerance. This new approach has the potential to treat autoimmune diseases, allergies and drug induce…

Articles about Topas Therapeutics' Series A Round: